Newsgroup sci.chem 72389

Directory

Subject: The Heart of the Firestorm -- From: "Charles P. McCarthy"
Subject: Re: A photon - what is it really ? -- From: tdp@ix.netcom.com(Tom Potter)
Subject: Re: PATNEWS: Chomsky on India, GATT, Pharmaceutical Patents, 3rd World -- From: "Eric Lucas"
Subject: Re: Thermochromatic Effect -- From: dsmall@pcisys.net
Subject: Re: PATNEWS: Chomsky on India, GATT, Pharmaceutical Patents, 3rd World -- From: ram@mbisgi.umd.edu (Ram Samudrala)

Articles

Subject: The Heart of the Firestorm
From: "Charles P. McCarthy"
Date: Mon, 11 Nov 1996 16:46:24 -0800
The Heart of the Firestorm
Activation, Anergy, and Apoptosis -gp120 and IL-2
Liegler and Stites demonstrated the in vitro restoration of
proliferation in CD4+ T-lymphocytes by IL-2  following anergy
induction via HIV glycoprotein 120 (gp120) .  If this type of
restoration is not seen in patients with advanced HIV disease
following in vivo infusions of IL-2 it is because of high 
levels of viral antigen .  
In filariasis we see this same phenomenon of increasing anergy 
proportionate to the levels of parasite antigens.  In the case 
of HIV infection, the effect, extent and duration of IL-2 
proliferation restoration would be determined by the amount of 
gp120 being secreted in vivo. 
HIV gp120 not only provides the molecular basis of aberrant
activation and anergy, due to its dual properties of CD4 binding 
and MHC mimicry, but also its membrane interactions with CD4, 
transglutaminase, etc. are the molecular basis for apoptosis in 
HIV infection.  
Cohen et al demonstrated the markers that can be used to
differentiate between physiological apoptosis and the mitotic 
chaos that occurs in HIV infection.
The pathology of AIDS is the sequelae that results from the
secretion of gp120 by host cells infected with HIV and the
interaction of this glycoprotein with target cells.  
Abnormal flux of Ca++ into intracellular compartments resulting
from gp120/host membrane interactions, is a fundamental ionic
signal to all messenger molecules.  It propagates the aberrant 
lipid metabolism that supports viral assembly and budding while 
infected cells rapidly burn to the ground.  The glowing gp120 
embers from the firestorm drive uninfected immune cells to a 
fiery, premature death. 
Endogenous or exogenous agents that directly or indirectly 
reduce gp120 secretion, compete effectively with its binding 
sites, or reduce its passage through host cell membranes, will
produce sustainable therapeutic advances.  To the degree that 
they are sustained by interventions that may be circumvented 
by mutation and selection, they will be relatively short-lived.
Saturating doses of natural, small molecule, metabolic 
immunomodulators appears to be the treatment of choice.
Any and all researchers with g.c. facilities please 
inquire via email for current priorities in isolation 
and identification.  Thank you.
"Life is a membrane that reproduces."
                         Pandoc
Charles P. McCarthy, Clinical Specialist
Healthcare Consulting and
   Medical Research
Professor Emeritus of Pantherapeuticological Medicine
Carmichael, CA USA
Cohen DI; Hartmann DP; Donoghue E; Raffeld M
A central mechanism of HIV-mediated apoptosis.
Laboratory of Immunoregulation, NIAID, Bethesda, MD.
Natl Conf Hum Retroviruses Relat Infect (1st). 1993 Dec 12-16;
150.
Abstract: 
Although it has been widely proposed that apoptosis or
programmed cell death (PCD) plays a central role in HIV- mediated
T cell killing, no previous report has linked this observation to a
defined cellular mechanism explaining the cell death. We have
previously established that the HIV- initiated form of PCD
differs from most common forms of T cell developmental PCD
insofar as tyrosine kinases play a central role in initiating the
HIV-mediated process (Cohen et al., Science 256, 542, 1992). We
show here that single cell killing either during infection of
PBLs with ex vivo clinical HIV isolates or during co-culture of
cells transfected to express HIV envelope glycoproteins occurs
because cells are lethally arrested at the G2/M cell cycle
interface and undergo a death process termed mitotic catastrophe.
Cells dying of HIV-mediated apoptosis overaccumulate activated
forms of two mitotic regulators, cyclin B and p34cdc2 kinase,
which in conjunction have been previously demonstrated in other
systems to cause mitotic catastrophe. We further find that the
cells undergoing HIV- directed PCD have profoundly excessive
levels of phosphorylated p34cdc2 kinase, reflecting hyperactivity
of the wee1+ kinase which is the cellular enzyme responsible for
cdc2 phosphorylation. Since overactivity of wee1 + kinase in
numerous systems has been shown to directly and dramatically
increase cell size, its overactivity in cells dying of HIV PCD
apparently explains the balloon cytopathicity seen in
HIV-infected cultures. This work is the first report defining a
basic cellular mechanism operative during virally-initiated
apoptosis. Because the mechanism of PCD utilized by HIV to kill T
cells apparently does not participate in normal T cell
development, HIV- mediated apoptosis appears to represent an
unusual killing program which potentially renders it more
susceptible to specific disruption by therapeutic agents.
Liegler TJ; Stites DP 
HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness 
in peripheral CD4 T lymphocytes.
J Acquir Immune Defic Syndr
1994 Apr Issue/Part/Supplement: 4 Volume Issue: 7 Pagination:
340-8
Human immunodeficiency virus type 1 (HIV-1) gp-120 potentially
plays an important role in inducing functional suppression and
depletion of CD4 lymphocytes following infection with HIV. In order
to further understand the mechanisms involved in HIV-induced
immunosuppression, we have studied the effects of recombinant
HIV-1 gp120/SF2 and anti-gp120/SF2 antibodies on T cell receptor
(TCR)-mediated proliferation of peripheral blood mononuclear cells
(PBMCs) and isolated lymphocyte subsets from HIV-seronegative
donors. In a dose-dependent manner, gp120 significantly reduces
the proliferative responses of unfractionated PBMCs and highly
enriched CD4 T lymphocytes when they are polyclonally stimulated
through the TCR using WT31 (anti-alpha beta Ti chains) and anti-
Leu 4 (anti-CD3 epsilon) in the presence of autologous accessory
cells. The addition of divalent anti-gp120/SF2 to lymphocytes
previously incubated with gp120 further reduces the proliferation to
the levels seen after pretreating cells with divalent anti-CD4 (anti-
Leu 3a). CD8 T lymphocytes, on the other hand, show no change in
TCR-mediated proliferation following preincubation with either anti-
CD4 or gp120/anti-gp120. We find no evidence for significant cell
death by apoptosis using methods of DNA analysis or flow
cytometry and DNA-specific dyes to account for the loss of CD4
lymphocyte proliferation.  Interleukin-2 restores the proliferation
suppressed by gp120/anti-gp120 suggesting the induction of
reversible functional anergy.
Department of Laboratory Medicine, University of California, San
Francisco.
Return to Top
Subject: Re: A photon - what is it really ?
From: tdp@ix.netcom.com(Tom Potter)
Date: 11 Nov 1996 23:40:59 GMT
In <3287D0D5.C5E@stud.man.ac.uk> mbcx6prn@stud.man.ac.uk writes: 
>
>A photon is used in physics to explain certain properties of light.
>The best explanation of a photon I can give is that it's a travelling
>packet of energy with no mass but can exert a force on the medium it
>interacts with.
>
>Paul Norman.
A photon is not a thing,
it is the name for a cause or an effect.
A cause or an effect can be either
cyclical or an impulse.
Cyclical effects are associated with time,
and impulse effects are associated with space.
The "point" at which impulse effects are
observed are associated with objects.
Actually, these points are memory quanta,
rather than anything external.
In other words, time is cyclical,
space is the measure of the number
of cycles that occur between two
impulses, ( Multiplied by a constant "C". )
and objects, which are identified
with mass, are the memory quanta that
"stores" the time-space information.
( Multiplied by a constant "G". )
This is described in a few articles
at my Web site.
Tom Potter      http://pobox.com/~tdp
Return to Top
Subject: Re: PATNEWS: Chomsky on India, GATT, Pharmaceutical Patents, 3rd World
From: "Eric Lucas"
Date: 12 Nov 1996 00:11:39 GMT
Alan \"Uncle Al\" Schwartz  wrote:
> Chomsky is a superannuated fire eater who must resort to kindling his own
> fire.  He is the sort of malignant do-gooder who is willing to sacrifice 
> other people's children and drain everybody's wallet so that people too 
> stupid to use seatbelts might be saved by airbags.
I agree, but he's also one of the supreme intellects of the latter half of
the 20th century.  He revolutionized both linguitics and human
developmental science.  Which makes it a little hard for me to believe he
actually holds such unsophisticated beliefs on such a broad topic.  Is
there any independent corroboration that he said those words, or was this
someone just trolling for an argument?  (And what better place to troll for
an argument about IP than in sci.chem.)
	Eric Lucas
Return to Top
Subject: Re: Thermochromatic Effect
From: dsmall@pcisys.net
Date: Mon, 11 Nov 1996 18:11:05 -0600
X-Article-Creation-Date: Tue Nov 12 00:09:59 1996 GMT
X-Originating-IP-Addr: 207.76.102.135 ()
X-Authenticated-Sender: dsmall@pcisys.net
Lines: 24
Xref: magma.Mines.EDU sci.polymers:8568 sci.chem:72393
In article <3276FD4A.3C51@greenepa.net> ,
    Wayne Goates  wrote:
> 
> I have a T-shirt that will change color from a more or less drab gray 
> color to that of a blue and a yellow when exposed to the UV light of the 
> sun.  Does anyone know what company markets this Thermochromatic product 
> and if so, what is their address?  Thanks in advance. 
> ----------
> Wayne Goates   Email:goat5200@spacelink.msfc.nasa.gov
> 
Wayne,
The T-shirt you're referring to is Photochromic (UV light sensitive)-- not 
Thermochromic (Heat sensitive).  My company, Chromatic Technologies, Inc.,
(www.lightlink.com/cti/) offers both these types of inks, as well as finished
products, like T-shirts and other promotional products.
If you would like further info., please call us at (719) 592-1557. 
- Danny 
-----------------------------------------------------------------------
This article was posted to Usenet via the Posting Service at Deja News:
http://www.dejanews.com/           [Search, Post, and Read Usenet News]
Return to Top
Subject: Re: PATNEWS: Chomsky on India, GATT, Pharmaceutical Patents, 3rd World
From: ram@mbisgi.umd.edu (Ram Samudrala)
Date: 12 Nov 1996 01:05:27 GMT
Bruce Hayden (bhayden@copatlaw.com) wrote:
>The mentality of "inventors" and "creators" is close to irrelevant
>here. 
On the contrary, if assertions of the form "without an economic
incentive people wouldn't invent and create" are thrown about, the
mentality of inventors and creators do become relevant.  Andy's exact
words were: "...nobody really has any incentive to invent."  Obviously
false.
>> I'm suggesting a lot of discoveries and writings were created without
>> IP laws just fine.
>And a lot more have been made with them.
That doesn't prove IP laws helped.  A lot /more/ could have been made
without IP laws.  A lot more progress might've been achieved without
IP laws.  Even if the exact same amount of progress would've been
achieved, it still wouldn't justify the existence of IP laws.
>I seem to be missing your point. You argue that the Rennaisance happened
>without strong IP laws.
Just a nitpick, but I didn't mention the Rennaisance.  
>Andy comes back and points out that the industrial revolution
>happened with much stronger IP laws.
Yes, but that doesn't justify their existence, or his statements that
"nobody really has any incentive to invent" if free-riding were
permitted. 
>comparison with today, the amount of innovation was almost negligent.
Do you honestly believe that amount of innovation is a linear function
with time?  Don't you think technological progress is the result of a
snowball effect?  Compared to the caveman days, the amount of
innovation 1000 years ago was amazing.  Why?  Seriously, if you wish
to mention amount, don't you think it has to be normalised somehow for
other factors?
Actually compared to the technological innovation just a 100 years
ago, the current amount of innovation is tremendous, even though both
periods had patent laws.  Heck, compared to last year, this year's
innovations seems even more (especially in the biotech industry as I
feel it since I'm close to it).  I doubt patent laws have anything to
do with technological innovation, and if they did, using "amount" to
measure any correlation without some sort of normalisation is simply
wrong.
>Finally, the question is not whether an industry would survive withot
>patent laws, but rather where would it be without patent laws. And of
>course we can't know for sure. But without strong patent laws, the
>drug industry would probably not be near as strong.
I honestly don't see this at all.  You're assuming here that the
patent laws as we know them are the only means by which a profit can
be made. Also, I'll refer to Gregory Aharonian's data (which I suspect
he regrets he posted now :) to show that the pharmaceutical industry
could be doing quite fine even with a very limited number of years of
exclusive use.  
>In other words, you are arguing that causation can't be proven, and
>apparently, correlation isn't reliable in your view.
I'm sorry, I don't even see the correlation.  I can't even begin to
see how "innovation" would be measured in some normalised manner.  
>the government still makes decisions based on this imperfect
>information
Return to Top

Downloaded by WWW Programs
Byron Palmer